Sleeve-pneumonectomy for lung cancer – survival and complications (update 2005) Source: Eur Respir J 2005; 26: Suppl. 49, 492s Year: 2005
Stage, therapy and surviving of small cell lung cancer: analysis of a nonselected patient collective 1993-1997 Source: Eur Respir J 2001; 18: Suppl. 33, 394s Year: 2001
Enrolment in clinical trials enhances the survival benefit provided to lung cancer patients Source: International Congress 2016 – Prognostic variables in lung cancer II Year: 2016
Smoking status in Danish lung cancer patients compared to the general population, 2005 - 2013 Source: International Congress 2016 – Epidemiology and specific subgroups in lung cancer Year: 2016
Improvement of the survival of lung cancer in a French monocentric cohort between 1990 and 2010 Source: Annual Congress 2011 - Quality management for lung cancer patients Year: 2011
Time to diagnosis and time to therapy in patients with malignant pleural mesothelioma (MPM) compared to patients with lung cancer in Denmark 2007 to 2011. A quality assurance analysis Source: Annual Congress 2012 - Biology and treatment of malignant pleural effusions Year: 2012
Analysis of epidemiological differences and occupations risk of lung cancer cases between 1995-2008 years in Turkey Source: Annual Congress 2009 - Clinical aspects and epidemiology in lung cancer Year: 2009
Gefitinib in the non small cell lung cancer treatment: contribution to prolongation and quality of survival Source: Eur Respir J 2004; 24: Suppl. 48, 303s Year: 2004
Real-world treatment patterns and outcomes of patients with extensive disease small cell lung cancer (ED SCLC) Source: International Congress 2019 – Treatment of lung cancer Year: 2019
Time trends in surgery for lung cancer in France from 2005 to 2012: a nationwide study Source: Eur Respir J 2015; 46: 1131-1139 Year: 2015
The analysis of lung cancer patients (LCP) survival during one-year period after diagnosing of disease Source: Eur Respir J 2006; 28: Suppl. 50, 88s Year: 2006
Lung cancer survival in the UK: are the results from the national lung cancer audit (LUCADA) dependent on completeness of case reporting? Source: Annual Congress 2009 - Epidemiology and management of lung cancer Year: 2009
Follow-up and surveillance for lung cancer Source: Annual Congress 2005 - MP5 - Follow-up and surveillance for lung cancer Year: 2005
Survival outcomes of non small cell lung cancer (NSCLC) patients who are suitable for radical treatment at initial presentation Source: Annual Congress 2011 - Quality management for lung cancer patients Year: 2011
Clinical characteristics, treatment, and prognosis of lung cancer elderly patients Source: Eur Respir J 2001; 18: Suppl. 33, 228s Year: 2001
Influence of neonatal screening and centralized treatment on long-term clinical outcome and survival of CF patients Source: Eur Respir J 2001; 18: 306-315 Year: 2001
Surrogate markers predicting overall survival for lung cancer: ELCWP recommendations Source: Eur Respir J 2011; 39: 9-28 Year: 2012
Surrogate markers predicting overall survival for lung cancer: ELCWP recommendations Source: Eur Respir J 2012; 39: 9-28 Year: 2012
A retrospective study of the cause and impact of delayed diagnosis of lung cancer (LC) Source: Annual Congress 2008 - Management, quality aspects and prognosis in thoracic oncology Year: 2008
Comparison of non-small cell lung cancer (NSCLC) management and survival in 1995 and 2005 at a London teaching hospital Source: Annual Congress 2008 - Management, quality aspects and prognosis in thoracic oncology Year: 2008